Strategic Initiative

Slingshot members are tracking this corporate initiative:

Sunovion Pharmaceuticals Acquires Cynapsus Therapeutics for US$40.50 per share in cash

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Sunovion Pharmaceuticals


Additional Information

Additional Relevant Details The transaction has received unanimous approval by the Board of Directors of both companies and values Cynapsus at approximately US$624 million (or approximately CAN$820 million). The acquisition will be funded with cash on hand. The transaction is expected to close in the fourth quarter of 2016 (third quarter of Sunovion’s fiscal year). This agreement reflects Sunovion’s global strategy to expand and diversify its portfolio in key therapeutic areas, including neurology.
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Aug 31, 2016
Projected Implementation:
Q3, 2016
Relevance Tracked Until:
Q4, 2016
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Apl-130277